Clinical trial · Observational
Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP)
Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCap)
NCT02583815CI-TRIAL-00032886PAMCapcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is an open label feasibility pilot study of commercially available physical activity monitoring devices in patients receiving systemic therapy at the Harold Simmons Cancer Center, UT Southwestern Medical Center.
Conditions
Conditions (9)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Endocrine Cancer | Malignant Endocrine Neoplasm | ALIAS | 0.90 |
| Gastrointestinal Cancer | Malignant Digestive System Neoplasm | ALIAS | 0.90 |
| Genitourinary Cancer | Malignant Genitourinary System Neoplasm | ALIAS | 0.90 |
| Gynecologic Cancer | Malignant Female Reproductive System Neoplasm | ALIAS | 0.90 |
| Leukemia | Leukemia | ONTOLOGY_EXACT | 0.90 |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Male Genital Cancer | Malignant Male Reproductive System Neoplasm | ALIAS | 0.90 |
| Skin Cancer | Malignant Skin Neoplasm | ALIAS |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Cancer Patients
- description
- This is an open label feasibility pilot study of commercially available physical activity monitoring devices in patients receiving systemic therapy at the Harold Simmons Cancer Center, UT Southwestern Medical Center.
Primary outcomes (1)
- measure
- Number of Participants Who Use PAM Device
- timeFrame
- Week 6 until week 12
- description
- The primary endpoint of the study is the feasibility defined by subjects who use a PAM device for more than 42 of 84 days in the observation period (12 weeks +/- 14 days)
Secondary outcomes (8)
- measure
- Number of Steps
- timeFrame
- 12 Weeks (+/- 14 days)
- description
- The number of steps will be collected over the course of 12 weeks to help determine the amount of physical activity is being done. The Physical activity monitor is able to track this.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Signed informed consent * Age 18 or above * Receiving or planning to receive outpatient therapy for any cancer * Baseline ECOG status 0-2; * Speak and understand English as all Psychological assessment tools included in this study have not been validated in Spanish; * Access to smartphone device compatible to sync with PAM Device Exclusion Criteria: * Recent injury which may result in impaired mobility; * Major surgery within 4 weeks or till recovery to baseline functioning (per patient) whichever is shorter; * Inability to comply with study requirement; * Medical, psychiatric condition which in the investigators opinion will affect the successful completion of study; * Current use of a wearable PAM device as defined by use of PAM device in the last 6 months
References
Publications (0)
Data not yet available
No reference posted for this study.